Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1995-09-08
1997-11-25
Higel, Floyd D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
5142335, 5142352, 5142355, 5142358, 544132, 544134, 544139, 544141, 544143, C07D26532, C07D27912, C07D41304, C07D41306, C07D41314
Patent
active
056913362
ABSTRACT:
Substituted heterocycles of the general structural formula: ##STR1## are tachykinin receptor antagonists useful in the treatment of inflammatory diseases, pain or migraine, asthma, and emesis.
REFERENCES:
patent: 2943022 (1960-06-01), Siemer et al.
patent: 3005818 (1961-10-01), Siemer et al.
patent: 3458509 (1969-07-01), Levine et al.
patent: 3506673 (1970-04-01), Warawa et al.
patent: 3541090 (1970-11-01), Herlinger et al.
patent: 4010266 (1977-03-01), McLoughlin et al.
patent: 4360519 (1982-11-01), White et al.
patent: 4476311 (1984-10-01), Shetty et al.
patent: 4705553 (1987-11-01), Buschmenn et al.
patent: 4782054 (1988-11-01), Regnier et al.
patent: 4943578 (1990-07-01), Naylor et al.
patent: 5064838 (1991-11-01), Carr et al.
patent: 5095021 (1992-03-01), Zipplies et al.
Advenier, et al., "Neurokinin A (NK2) Receptor Revisited With SR48968 . . . ", Biochem. and Biophys., Res. Comm., 184(3), pp. 1418-1424 (1992).
Edmonds-Alt, et al., "A Potent and Selective Non-Peptide Antagonist of the Neurokinin A (NK2) Receptor", Life Sci., 50, pp. PL101-PL106 (1992).
Frossard, et al. "Tachykinin Receptors and the Airways", Life Sci., 49, pp. 1491-1953, (1991).
Guthrie, et al., "The Use of Periodate-Oxidized Glycosides in the Robinson-Schopf . . . ", J. Chem. Society, vol. C(1), pp. 62-66 (1967).
Howson, et al., "An SAR Study for the Non-Peptide Substance P Receptor . . . ", Biorg. & Med. Chem. Lett., vol. 2(6), pp. 559-564 (1992).
G. Rucker, et al., Arch. Pharm., (Weinheim, Ger.) 315(10), 839-846 (1982), "Stabilitasuntersuchungen and Phenylethylaminsubstituierten Pyrazolonein".
Chem. Abstracts, 73 (3) p. 361, No. 14777c (Jul. 20, 1970), "Diastereoisomeric Configuration of Morpholine Derivatives".
I.V. Bozhko, et al., Kinet. Katal., 31 (3), 737-738 (1990) (Russ.).
Lowe, et al., "The Discovery of (2S,3S)-cis-2(Diphenylmethyl)-N-(2-methoxyphenyl)methyl . . . ", J. Med. Chem., vol. 35, pp. 2591-2600 (1992).
McCormick, "Properties of Periodate-Oxidised Polysaccharides", J. Chem. Society, vol. C(23), pp. 2121-2127 (1966).
Montgomery, et al., "2-Fluoropurine Ribonucleosides", J. of Med. Chem., vol. 13(3), pp. 421-427 (1970).
Payan, et al., "Substance P. Recognition by a Subset of Human T Lymphocytes", J. Clin. Invest., 74, 1532-1539 (1984).
Peyronel, et al., "Synthesis of RP-67,580, a New Potent Nonpeptide Subtance P Antagonist", Biorg. and Med. Chem. Lett., vol. 2(6), pp. 559-564 (1992).
Siemer, et al., "Analgesic 1-phenyl-2,3-dimethyl-4-morpholinomethyl-3-pyrazolin-5-ones . . . " Chem. Abstracts, 56, No. 6, No. 5977e (1962).
Chem. Abstracts, 113 (20) p. 123, No. 174441m (Nov. 12, 1990), "Amine Hydrochlorides-Catalysts for Hydrochlorination".
Sinkula, et al., "Rationale for Design of Biologically Reversible Drug Derivatives: Prodrugs", J. Pharm. Sciences, 64 (2), pp. 181-210 (1975).
Svensson, "Prodrugs: metabolism-based drug design", Pharmaceutisch Weekblad, 122, pp. 245-250, (1987).
Balant, et al., "Prodrugs for the improvement of drug absorption via different routes of administration.", Eur. J. Drug Metab. Pharmaco., 15(2), pp. 143-153, (1990).
Bodar, et al., "Novel Approaches in Prodrug Design", Drugs Future, VI(3), pp. 165-182 (1981).
Bundgaard, "The double prodrug concept and its applications", Adv. Drug Delivey Rev., 3 pp. 39-65, (1989).
Dorn Conrad P.
Hale Jeffrey J.
Maccoss Malcolm
Mills Sander G.
Higel Floyd D.
Merck & Co. , Inc.
Rose David L.
Thies J. Eric
LandOfFree
Morpholine compounds are prodrugs useful as tachykinin receptor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Morpholine compounds are prodrugs useful as tachykinin receptor , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Morpholine compounds are prodrugs useful as tachykinin receptor will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2107336